TreeWAS – Variant ID: rs71568191

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
R26.8 Other and unspecified abnormalities of gait and mobility	0.100	0.900
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.090	0.910
R26 Abnormalities of gait and mobility	0.082	0.918
R26.2 Difficulty in walking, not elsewhere classified	0.073	0.927
R26.0 Ataxic gait	0.068	0.932
R26.3 Immobility	0.063	0.936
R26.1 Paralytic gait	0.059	0.941
O62.2 Other uterine inertia	0.056	0.944
O62 Abnormalities of forces of labour	0.052	0.948
O60-O75 Complications of labour and delivery	0.050	0.950
O66 Other obstructed labour	0.045	0.955
O75 Other complications of labour and delivery, not elsewhere classified	0.044	0.956
O71 Other obstetric trauma	0.043	0.956
O64 Obstructed labour due to malposition and malpresentation of foetus	0.043	0.957
O66.0 Obstructed labour due to shoulder dystocia	0.042	0.958
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.042	0.958
O63 Long labour	0.041	0.959
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.040	0.960
O71.4 Obstetric high vaginal laceration alone	0.040	0.960
O61 Failed induction of labour	0.039	0.961
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.039	0.961
O72 Postpartum haemorrhage	0.038	0.962
O62.1 Secondary uterine inertia	0.038	0.962
O62.9 Abnormality of forces of labour, unspecified	0.037	0.962
O62.8 Other abnormalities of forces of labour	0.037	0.962
O62.0 Primary inadequate contractions	0.037	0.962
O69 Labour and delivery complicated by umbilical cord complications	0.036	0.963
O73 Retained placenta and membranes, without haemorrhage	0.036	0.964
O74 Complications of anaesthesia during labour and delivery	0.036	0.964
O65 Obstructed labour due to maternal pelvic abnormality	0.036	0.964
O60 Preterm delivery	0.036	0.964
O63.9 Long labour, unspecified	0.036	0.964
O75.7 Vaginal delivery following previous Caesarean section	0.036	0.964
O75.2 Pyrexia during labour, not elsewhere classified	0.035	0.965
O75.8 Other specified complications of labour and delivery	0.035	0.965
O75.0 Maternal distress during labour and delivery	0.035	0.965
O63.0 Prolonged first stage (of labour)	0.034	0.966
O66.9 Obstructed labour, unspecified	0.032	0.968
O66.8 Other specified obstructed labour	0.032	0.968
O66.4 Failed trial of labour, unspecified	0.032	0.968
O66.3 Obstructed labour due to other abnormalities of foetus	0.032	0.968
O66.2 Obstructed labour due to unusually large foetus	0.032	0.968
O66.1 Obstructed labour due to locked twins	0.032	0.968
O72.2 Delayed and secondary postpartum haemorrhage	0.032	0.968
O61.0 Failed medical induction of labour	0.032	0.968
C15.5 Lower third of oesophagus	0.032	0.968
C15.9 Oesophagus, unspecified	0.032	0.968
O75.9 Complication of labour and delivery, unspecified	0.031	0.968
O75.5 Delayed delivery after artificial rupture of membranes	0.031	0.968
O75.4 Other complications of obstetric surgery and procedures	0.031	0.968
O75.3 Other infection during labour	0.031	0.968
O75.1 Shock during or following labour and delivery	0.031	0.968
O71.9 Obstetric trauma, unspecified	0.031	0.969
O71.7 Obstetric haematoma of pelvis	0.031	0.969
O71.6 Obstetric damage to pelvic joints and ligaments	0.031	0.969
O71.5 Other obstetric injury to pelvic organs	0.031	0.969
O71.3 Obstetric laceration of cervix	0.031	0.969
O71.2 Postpartum inversion of uterus	0.031	0.969
O71.1 Rupture of uterus during labour	0.031	0.969
O71.0 Rupture of uterus before onset of labour	0.031	0.969
O67.9 Intrapartum haemorrhage, unspecified	0.031	0.969
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.031	0.969
O64.8 Obstructed labour due to other malposition and malpresentation	0.031	0.969
O64.5 Obstructed labour due to compound presentation	0.031	0.969
O64.4 Obstructed labour due to shoulder presentation	0.031	0.969
O64.3 Obstructed labour due to brow presentation	0.031	0.969
O64.2 Obstructed labour due to face presentation	0.031	0.969
C15 Malignant neoplasm of oesophagus	0.031	0.969
O69.8 Labour and delivery complicated by other cord complications	0.031	0.969
O68 Labour and delivery complicated by foetal stress [distress]	0.030	0.970
O62.3 Precipitate labour	0.030	0.970
O63.2 Delayed delivery of second twin, triplet, etc.	0.030	0.970
O71.8 Other specified obstetric trauma	0.029	0.971
O69.0 Labour and delivery complicated by prolapse of cord	0.029	0.971
O61.9 Failed induction of labour, unspecified	0.028	0.971
O61.8 Other failed induction of labour	0.028	0.971
O61.1 Failed instrumental induction of labour	0.028	0.971
O67.8 Other intrapartum haemorrhage	0.028	0.972
O67.0 Intrapartum haemorrhage with coagulation defect	0.028	0.972
Y40 Systemic antibiotics	0.028	0.972
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.028	0.972
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.027	0.972
O72.3 Postpartum coagulation defects	0.027	0.973
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.027	0.973
O73.1 Retained portions of placenta and membranes, without haemorrhage	0.026	0.973
O69.5 Labour and delivery complicated by vascular lesion of cord	0.026	0.974
O69.4 Labour and delivery complicated by vasa praevia	0.026	0.974
O69.3 Labour and delivery complicated by short cord	0.026	0.974
O73.0 Retained placenta, without haemorrhage	0.026	0.974
O60.3 Preterm delivery without spontaneous labour	0.026	0.974
O60.2 Preterm spontaneous labour with term delivery	0.026	0.974
O60.1 Preterm spontaneous labour with preterm delivery	0.026	0.974
O60.0 Preterm labour without delivery	0.026	0.974
O65.9 Obstructed labour due to maternal pelvic abnormality, unspecified	0.026	0.974
O65.8 Obstructed labour due to other maternal pelvic abnormalities	0.026	0.974
O65.5 Obstructed labour due to abnormality of maternal pelvic organs	0.026	0.974
O65.4 Obstructed labour due to foetopelvic disproportion, unspecified	0.026	0.974
O65.3 Obstructed labour due to pelvic outlet and midcavity contraction	0.026	0.974
O65.2 Obstructed labour due to pelvic inlet contraction	0.026	0.974
O65.1 Obstructed labour due to generally contracted pelvis	0.026	0.974
O65.0 Obstructed labour due to deformed pelvis	0.026	0.974
O74.9 Complication of anaesthesia during labour and delivery, unspecified	0.026	0.974
O74.8 Other complications of anaesthesia during labour and delivery	0.026	0.974
O74.7 Failed or difficult intubation during labour and delivery	0.026	0.974
O74.6 Other complications of spinal and epidural anaesthesia during labour and delivery	0.026	0.974
O74.5 Spinal and epidural anaesthesia-induced headache during labour and delivery	0.026	0.974
O74.4 Toxic reaction to local anaesthesia during labour and delivery	0.026	0.974
O74.3 Central nervous system complications of anaesthesia during labour and delivery	0.026	0.974
O74.2 Cardiac complications of anaesthesia during labour and delivery	0.026	0.974
O74.1 Other pulmonary complications of anaesthesia during labour and delivery	0.026	0.974
O74.0 Aspiration pneumonitis due to anaesthesia during labour and delivery	0.026	0.974
C15.4 Middle third of oesophagus	0.026	0.974
Y40.1 Cefalosporins and other -lactam antibiotics	0.026	0.974
O72.1 Other immediate postpartum haemorrhage	0.026	0.974
Y40.0 Penicillins	0.026	0.974
O64.1 Obstructed labour due to breech presentation	0.025	0.975
O72.0 Third-stage haemorrhage	0.025	0.975
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.025	0.975
Y42.5 Other oestrogens and progestogens	0.025	0.975
Y44 Agents primarily affecting blood constituents	0.025	0.975
C15.3 Upper third of oesophagus	0.025	0.975
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.025	0.975
O69.9 Labour and delivery complicated by cord complication, unspecified	0.024	0.975
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.024	0.976
Y40.8 Other systemic antibiotics	0.024	0.976
Y44.2 Anticoagulants	0.024	0.976
O69.2 Labour and delivery complicated by other cord entanglement	0.023	0.977
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.023	0.977
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.023	0.977
Y40.9 Systemic antibiotic, unspecified	0.023	0.977
Y47 Sedatives, hypnotics and antianxiety drugs	0.023	0.977
C15.8 Overlapping lesion of oesophagus	0.022	0.978
C15.2 Abdominal part of oesophagus	0.022	0.978
C15.1 Thoracic part of oesophagus	0.022	0.978
C15.0 Cervical part of oesophagus	0.022	0.978
Y45.0 Opioids and related analgesics	0.022	0.978
O69.1 Labour and delivery complicated by cord around neck, with compression	0.021	0.978
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.021	0.979
Y53 Agents primarily affecting the gastro-intestinal system	0.021	0.979
Chapter XX External causes of morbidity and mortality	0.021	0.979
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.021	0.979
Y40.7 Antifungal antibiotics, systemically used	0.020	0.980
Y40.6 Rifamycins	0.020	0.980
Y40.5 Aminoglycosides	0.020	0.980
Y40.4 Tetracyclines	0.020	0.980
Y40.2 Chloramphenicol group	0.020	0.980
W00-W19 Falls	0.020	0.980
Y47.1 Benzodiazepines	0.020	0.980
Y59 Other and unspecified vaccines and biological substances	0.019	0.981
Y58 Bacterial vaccines	0.019	0.981
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.019	0.981
Y50 Central nervous system stimulants, not elsewhere classified	0.019	0.981
O63.1 Prolonged second stage (of labour)	0.019	0.981
V20-V29 Motorcycle rider injured in transport accident	0.019	0.981
Y48 Anaesthetics and therapeutic gases	0.019	0.981
Y45.5 4-Aminophenol derivatives	0.019	0.981
Y49 Psychotropic drugs, not elsewhere classified	0.018	0.982
Y44.5 Thrombolytic drugs	0.018	0.982
Y46 Antiepileptics and anti-Parkinsonism drugs	0.018	0.982
Y44.9 Other and unspecified agents affecting blood constituents	0.018	0.982
Y44.7 Plasma substitutes	0.018	0.982
Y44.6 Natural blood and blood products	0.018	0.982
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.018	0.982
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.018	0.982
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.018	0.982
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.018	0.982
Y40.3 Macrolides	0.018	0.982
Y42.9 Other and unspecified hormone antagonists	0.018	0.982
Y42.4 Oral contraceptives	0.018	0.982
Y42.2 Antithyroid drugs	0.018	0.982
Y42.1 Thyroid hormones and substitutes	0.018	0.982
W10 Fall on and from stairs and steps	0.018	0.982
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.017	0.982
Y54.5 Other diuretics	0.017	0.982
Y57 Other and unspecified drugs and medicaments	0.017	0.983
V40-V49 Car occupant injured in transport accident	0.017	0.983
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.017	0.983
Y42.7 Androgens and anabolic congeners	0.017	0.983
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.017	0.983
V28 Motorcycle rider injured in noncollision transport accident	0.017	0.983
Y45.2 Propionic acid derivatives	0.017	0.983
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.017	0.983
Y45.4 Antirheumatics	0.017	0.983
V01-V09 Pedestrian injured in transport accident	0.017	0.983
Y00-Y09 Assault	0.017	0.983
W07 Fall involving chair	0.017	0.983
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.017	0.983
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.017	0.983
Y51 Drugs primarily affecting the autonomic nervous system	0.016	0.983
W08 Fall involving other furniture	0.016	0.983
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.016	0.983
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.016	0.983
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.016	0.983
Y47.4 Bromine compounds	0.016	0.983
Y47.3 Paraldehyde	0.016	0.983
Y47.2 Chloral derivatives	0.016	0.983
Y47.0 Barbiturates, not elsewhere classified	0.016	0.983
Y42.0 Glucocorticoids and synthetic analogs	0.016	0.984
V70-V79 Bus occupant injured in transport accident	0.016	0.984
Y45.8 Other analgesics and antipyretics	0.016	0.984
W15 Fall from cliff	0.016	0.984
Y41 Other systemic anti-infectives and antiparasitics	0.016	0.984
W06 Fall involving bed	0.016	0.984
W03 Other fall on same level due to collision with, or pushing by, another person	0.016	0.984
V80-V89 Other land transport accidents	0.016	0.984
Y45.1 Salicylates	0.016	0.984
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.016	0.984
V28.9 Unspecified motorcycle rider injured in traffic accident	0.016	0.984
O85-O92 Complications predominantly related to the puerperium	0.016	0.984
W11 Fall on and from ladder	0.016	0.984
X10-X19 Contact with heat and hot substances	0.016	0.984
Y56.9 Topical agent, unspecified	0.015	0.984
Y56.8 Other topical agents	0.015	0.984
Y56.7 Dental drugs, topically applied	0.015	0.984
Y56.6 Otorhinolaryngological drugs and preparations	0.015	0.984
Y56.5 Ophthalmological drugs and preparations	0.015	0.984
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.015	0.984
Y56.3 Emollients, demulcents and protectants	0.015	0.984
Y56.2 Local astringents and local detergents	0.015	0.984
Y56.1 Antipruritics	0.015	0.984
O90 Complications of the puerperium, not elsewhere classified	0.016	0.984
W50-W64 Exposure to animate mechanical forces	0.016	0.984
W05 Fall involving wheelchair	0.015	0.984
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.015	0.985
U80.0 Penicillin resistant agent	0.015	0.985
W19 Unspecified fall	0.015	0.985
X60-X84 Intentional self-harm	0.015	0.985
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.015	0.985
Y53.7 Emetics	0.015	0.985
Y53.6 Antidiarrhoeal drugs	0.015	0.985
Y53.5 Digestants	0.015	0.985
Y53.4 Other laxatives	0.015	0.985
Y53.3 Saline and osmotic laxatives	0.015	0.985
Y53.2 Stimulant laxatives	0.015	0.985
Y53.1 Other antacids and anti-gastric-secretion drugs	0.015	0.985
Y53.0 Histamine H2-receptor antagonists	0.015	0.985
V27 Motorcycle rider injured in collision with fixed or stationary object	0.015	0.985
O85 Puerperal sepsis	0.015	0.985
X20-X29 Contact with venomous animals and plants	0.015	0.985
X40-X49 Accidental poisoning by and exposure to noxious substances	0.015	0.985
Y35-Y36 Legal intervention and operations of war	0.015	0.985
Y10-Y34 Event of undetermined intent	0.015	0.985
X85-X99 Assault	0.015	0.985
X30-X39 Exposure to forces of nature	0.015	0.985
X00-X09 Exposure to smoke, fire and flames	0.015	0.985
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.015	0.985
W75-W84 Other accidental threats to breathing	0.015	0.985
W65-W74 Accidental drowning and submersion	0.015	0.985
V98-V99 Other and unspecified transport accidents	0.015	0.985
V95-V97 Air and space transport accidents	0.015	0.985
V90-V94 Water transport accidents	0.015	0.985
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.015	0.985
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.015	0.985
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.015	0.985
Y54.9 Mineral salts, not elsewhere classified	0.015	0.985
Y54.8 Agents affecting uric acid metabolism	0.015	0.985
Y54.7 Agents affecting calcification	0.015	0.985
Y54.6 Electrolytic, caloric and water-balance agents	0.015	0.985
Y54.4 Loop [high-ceiling] diuretics	0.015	0.985
Y54.2 Carbonic-anhydrase inhibitors	0.015	0.985
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.015	0.985
Y54.0 Mineralocorticoids	0.015	0.985
Chapter XV Pregnancy, childbirth and the puerperium	0.015	0.985
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.015	0.985
W10.4 Street and highway	0.015	0.985
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.015	0.985
X58-X59 Accidental exposure to other and unspecified factors	0.015	0.985
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.015	0.985
W07.0 Home	0.015	0.985
W10.8 Other specified place	0.015	0.985
W16 Diving or jumping into water causing injury other than drowning or submersion	0.014	0.985
W14 Fall from tree	0.014	0.985
W12 Fall on and from scaffolding	0.014	0.985
W09 Fall involving playground equipment	0.014	0.985
W04 Fall while being carried or supported by other persons	0.014	0.985
W01 Fall on same level from slipping, tripping and stumbling	0.014	0.985
W00 Fall on same level involving ice and snow	0.014	0.985
V49 Car occupant injured in other and unspecified transport accidents	0.014	0.986
Y50.9 Central nervous system stimulant, unspecified	0.014	0.986
Y50.8 Other central nervous system stimulants	0.014	0.986
Y50.2 Methylxanthines, not elsewhere classified	0.014	0.986
Y50.1 Opioid receptor antagonists	0.014	0.986
Y50.0 Analeptics	0.014	0.986
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.014	0.986
Y55.6 Antiasthmatics, not elsewhere classified	0.014	0.986
Y55.5 Anticommon cold drugs	0.014	0.986
Y55.4 Expectorants	0.014	0.986
Y55.3 Antitussives	0.014	0.986
Y55.2 Other and unspecified agents primarily acting on muscles	0.014	0.986
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.014	0.986
Y55.0 Oxytocic drugs	0.014	0.986
Y58.9 Other and unspecified bacterial vaccines	0.014	0.986
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.014	0.986
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.014	0.986
Y58.5 Diphtheria vaccine	0.014	0.986
Y58.4 Tetanus vaccine	0.014	0.986
Y58.3 Plague vaccine	0.014	0.986
Y58.2 Cholera vaccine	0.014	0.986
Y58.1 Typhoid and paratyphoid vaccine	0.014	0.986
Y58.0 BCG vaccine	0.014	0.986
Y59.9 Vaccine or biological substance, unspecified	0.014	0.986
Y59.8 Other specified vaccines and biological substances	0.014	0.986
Y59.3 Immunoglobulin	0.014	0.986
Y59.2 Protozoal vaccines	0.014	0.986
Y59.1 Rickettsial vaccines	0.014	0.986
Y59.0 Viral vaccines	0.014	0.986
W08.0 Home	0.014	0.986
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.014	0.986
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.014	0.986
X50-X57 Overexertion, travel and privation	0.014	0.986
Y48.3 Local anaesthetics	0.014	0.986
V29 Motorcycle rider injured in other and unspecified transport accidents	0.014	0.986
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.014	0.986
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.014	0.986
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.014	0.986
V21 Motorcycle rider injured in collision with pedal cycle	0.014	0.986
V20 Motorcycle rider injured in collision with pedestrian or animal	0.014	0.986
Y48.5 Therapeutic gases	0.014	0.986
Y48.4 Anaesthetic, unspecified	0.014	0.986
Y48.1 Parenteral anaesthetics	0.014	0.986
Y48.0 Inhaled anaesthetics	0.014	0.986
O90.8 Other complications of the puerperium, not elsewhere classified	0.014	0.986
Y57.5 X-ray contrast media	0.014	0.986
Y04 Assault by bodily force	0.014	0.986
V04 Pedestrian injured in collision with heavy transport vehicle or bus	0.013	0.986
U80 Agent resistant to penicillin and related antibiotics	0.014	0.986
Y49.9 Psychotropic drug, unspecified	0.013	0.987
Y49.8 Other psychotropic drugs, not elsewhere classified	0.013	0.987
Y49.7 Psychostimulants with abuse potential	0.013	0.987
Y49.6 Psychodysleptics [hallucinogens]	0.013	0.987
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.013	0.987
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.013	0.987
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.013	0.987
Y49.0 Tricyclic and tetracyclic antidepressants	0.013	0.987
W15.8 Other specified place	0.013	0.987
V09 Pedestrian injured in other and unspecified transport accidents	0.013	0.987
W20-W49 Exposure to inanimate mechanical forces	0.013	0.987
Y91 Evidence of alcohol involvement determined by level of intoxication	0.013	0.987
W17 Other fall from one level to another	0.013	0.987
Y46.8 Antispasticity drugs	0.013	0.987
Y46.7 Anti-Parkinsonism drugs	0.013	0.987
Y46.5 Valproic acid	0.013	0.987
Y46.3 Deoxybarbiturates	0.013	0.987
Y46.1 Oxazolidinediones	0.013	0.987
Y46.0 Succinimides	0.013	0.987
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.013	0.987
W03.9 Unspecified place	0.013	0.987
W06.0 Home	0.013	0.987
Y48.2 Other and unspecified general anaesthetics	0.013	0.987
Y49.5 Other antipsychotics and neuroleptics	0.013	0.987
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.013	0.987
W13 Fall from, out of or through building or structure	0.013	0.987
Y46.6 Other and unspecified antiepileptics	0.013	0.987
V48 Car occupant injured in noncollision transport accident	0.013	0.987
Y46.4 Iminostilbenes	0.013	0.987
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.013	0.987
V43 Car occupant injured in collision with car, pick-up truck or van	0.013	0.987
V78 Bus occupant injured in noncollision transport accident	0.013	0.987
Y57.8 Other drugs and medicaments	0.013	0.987
Y54.3 Benzothiadiazine derivatives	0.013	0.987
W10.9 Unspecified place	0.013	0.987
W10.5 Trade and service area	0.013	0.987
W10.2 School, other institution and public administrative area	0.013	0.987
W10.0 Home	0.013	0.987
W10.7 Farm	0.013	0.987
W10.6 Industrial and construction area	0.013	0.987
W10.3 Sports and athletics area	0.013	0.987
W10.1 Residential institution	0.013	0.987
O90.1 Disruption of perineal obstetric wound	0.013	0.987
Y00 Assault by blunt object	0.013	0.987
O90.9 Complication of the puerperium, unspecified	0.013	0.987
Y57.7 Vitamins, not elsewhere classified	0.013	0.987
Y57.6 Other diagnostic agents	0.013	0.987
Y57.4 Pharmaceutical excipients	0.013	0.987
Y57.3 Alcohol deterrents	0.013	0.987
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.013	0.987
Y57.1 Lipotropic drugs	0.013	0.987
Y57.0 Appetite depressants [anorectics]	0.013	0.987
V47 Car occupant injured in collision with fixed or stationary object	0.013	0.987
V46 Car occupant injured in collision with other nonmotor vehicle	0.013	0.987
V45 Car occupant injured in collision with railway train or railway vehicle	0.013	0.987
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.013	0.987
V41 Car occupant injured in collision with pedal cycle	0.013	0.987
V40 Car occupant injured in collision with pedestrian or animal	0.013	0.987
W11.5 Trade and service area	0.013	0.987
W19.1 Residential institution	0.013	0.987
Y49.2 Other and unspecified antidepressants	0.012	0.987
O90.2 Haematoma of obstetric wound	0.013	0.987
Y43 Primarily systemic agents	0.013	0.987
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.012	0.987
V27.4 Driver injured in traffic accident	0.012	0.987
V28.4 Driver injured in traffic accident	0.012	0.987
V28.0 Driver injured in nontraffic accident	0.012	0.987
V28.5 Passenger injured in traffic accident	0.012	0.987
V28.3 Person injured while boarding or alighting	0.012	0.987
V28.2 Unspecified motorcycle rider injured in nontraffic accident	0.012	0.987
V28.1 Passenger injured in nontraffic accident	0.012	0.987
Y71 Cardiovascular devices associated with adverse incidents	0.012	0.988
Y46.2 Hydantoin derivatives	0.012	0.988
V06 Pedestrian injured in collision with other nonmotor vehicle	0.012	0.988
V05 Pedestrian injured in collision with railway train or railway vehicle	0.012	0.988
V03 Pedestrian injured in collision with car, pick-up truck or van	0.012	0.988
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle	0.012	0.988
V01 Pedestrian injured in collision with pedal cycle	0.012	0.988
U80.8 Agent resistant to other penicillin-related antibiotic	0.012	0.988
W05.0 Home	0.012	0.988
Y09 Assault by unspecified means	0.012	0.988
Y08 Assault by other specified means	0.012	0.988
Y07 Other maltreatment syndromes	0.012	0.988
Y06 Neglect and abandonment	0.012	0.988
Y05 Sexual assault by bodily force	0.012	0.988
Y03 Assault by crashing of motor vehicle	0.012	0.988
Y02 Assault by pushing or placing victim before moving object	0.012	0.988
Y01 Assault by pushing from high place	0.012	0.988
W07.2 School, other institution and public administrative area	0.012	0.988
W07.8 Other specified place	0.012	0.988
W07.7 Farm	0.012	0.988
W07.6 Industrial and construction area	0.012	0.988
W07.5 Trade and service area	0.012	0.988
W07.4 Street and highway	0.012	0.988
W07.3 Sports and athletics area	0.012	0.988
W07.1 Residential institution	0.012	0.988
Y91.9 Alcohol involvement, not otherwise specified	0.012	0.988
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.012	0.988
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.012	0.988
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.012	0.988
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.012	0.988
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.012	0.988
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.012	0.988
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.012	0.988
Y51.1 Other parasympathomimetics [cholinergics]	0.012	0.988
Y51.0 Anticholinesterase agents	0.012	0.988
W08.9 Unspecified place	0.012	0.988
W08.8 Other specified place	0.012	0.988
W08.7 Farm	0.012	0.988
W08.6 Industrial and construction area	0.012	0.988
W08.5 Trade and service area	0.012	0.988
W08.4 Street and highway	0.012	0.988
W08.3 Sports and athletics area	0.012	0.988
W08.2 School, other institution and public administrative area	0.012	0.988
W08.1 Residential institution	0.012	0.988
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.012	0.988
X12 Contact with other hot fluids	0.012	0.988
X47 Accidental poisoning by and exposure to other gases and vapours	0.012	0.988
Y77 Ophthalmic devices associated with adverse incidents	0.012	0.988
W07.9 Unspecified place	0.012	0.988
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.012	0.988
X65 Intentional self-poisoning by and exposure to alcohol	0.012	0.988
W60 Contact with plant thorns and spines and sharp leaves	0.012	0.988
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.012	0.988
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.012	0.988
V22.4 Driver injured in traffic accident	0.012	0.988
V79 Bus occupant injured in other and unspecified transport accidents	0.012	0.988
V77 Bus occupant injured in collision with fixed or stationary object	0.012	0.988
V76 Bus occupant injured in collision with other nonmotor vehicle	0.012	0.988
V75 Bus occupant injured in collision with railway train or railway vehicle	0.012	0.988
V74 Bus occupant injured in collision with heavy transport vehicle or bus	0.012	0.988
V73 Bus occupant injured in collision with car, pick-up truck or van	0.012	0.988
V72 Bus occupant injured in collision with two- or three-wheeled motor vehicle	0.012	0.988
V71 Bus occupant injured in collision with pedal cycle	0.012	0.988
V70 Bus occupant injured in collision with pedestrian or animal	0.012	0.988
W15.9 Unspecified place	0.012	0.988
W15.7 Farm	0.012	0.988
W15.6 Industrial and construction area	0.012	0.988
W15.5 Trade and service area	0.012	0.988
W15.4 Street and highway	0.012	0.988
W15.3 Sports and athletics area	0.012	0.988
W15.2 School, other institution and public administrative area	0.012	0.988
W15.1 Residential institution	0.012	0.988
W15.0 Home	0.012	0.988
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.012	0.988
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.012	0.988
Y41.5 Antiviral drugs	0.012	0.988
Y41.4 Anthelminthics	0.012	0.988
Y41.3 Other antiprotozoal drugs	0.012	0.988
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.012	0.988
Y41.1 Antimycobacterial drugs	0.012	0.988
Y41.0 Sulphonamides	0.012	0.988
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.012	0.988
W03.8 Other specified place	0.012	0.988
W03.3 Sports and athletics area	0.012	0.988
W03.7 Farm	0.012	0.988
W03.6 Industrial and construction area	0.012	0.988
W03.5 Trade and service area	0.012	0.988
W03.4 Street and highway	0.012	0.988
W03.2 School, other institution and public administrative area	0.012	0.988
W03.1 Residential institution	0.012	0.988
W03.0 Home	0.012	0.988
W06.2 School, other institution and public administrative area	0.012	0.988
W06.9 Unspecified place	0.012	0.988
W06.8 Other specified place	0.012	0.988
W06.7 Farm	0.012	0.988
W06.6 Industrial and construction area	0.012	0.988
W06.5 Trade and service area	0.012	0.988
W06.4 Street and highway	0.012	0.988
W06.3 Sports and athletics area	0.012	0.988
W06.1 Residential institution	0.012	0.988
W19.9 Unspecified place	0.012	0.988
V88 Nontraffic accident of specified type but victim's mode of transport unknown	0.012	0.988
V87 Traffic accident of specified type but victim's mode of transport unknown	0.012	0.988

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations